D'Abronzo F H, Higa O Z, Laudana A A, Lima S S
Horm Metab Res. 1984 Aug;16(8):435-8. doi: 10.1055/s-2007-1014810.
Serum somatomedin B (SmB) levels in cirrhotic individuals, 3.3 +/- 1.5 mg/l, were strikingly lower (P less than 0.001) than in normal subjects, 9.0 +/- 1.7 mg/l. SmB levels were clearly related to the levels of alpha 2-globulins in the cirrhotics (r = + 0.8, P less than 0.002). Serum SmB and growth hormone correlated negatively in a group of normal and cirrhotic individuals (r = -0.67, P less than 0.001). Direct measurements of serum SmB failed to reveal differences between hepatic, renal and peripheral veins. These findings suggest that: 1) SmB is produced by liver and/or normal liver function plays an important role in maintaining normal serum SmB levels; 2) SmB carrier proteins are reduced in the cirrhotics and 3) SmB is part of a negative feed-back system involving growth hormone.
肝硬化患者血清生长调节素B(SmB)水平为3.3±1.5mg/l,显著低于正常受试者的9.0±1.7mg/l(P<0.001)。肝硬化患者的SmB水平与α2球蛋白水平明显相关(r=+0.8,P<0.002)。在一组正常人和肝硬化患者中,血清SmB与生长激素呈负相关(r=-0.67,P<0.001)。直接检测血清SmB未能发现肝静脉、肾静脉和外周静脉之间存在差异。这些发现表明:1)SmB由肝脏产生和/或正常肝功能在维持正常血清SmB水平中起重要作用;2)肝硬化患者的SmB载体蛋白减少;3)SmB是涉及生长激素的负反馈系统的一部分。